Exelixis Inc. Common Stock vs Venture Global Inc. Class A common stock — how do they compare? Exelixis Inc. Common Stock trades at $60.1 (market cap $14.62B), while Venture Global Inc. Class A common stock trades at $13.15 (market cap $33.23B). The key difference: Venture Global Inc. Class A common stock is far larger — about 2.3× Exelixis Inc. Common Stock's market cap, and Venture Global Inc. Class A common stock pays a 1.2% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Venture Global Inc. Class A common stock for 0 Days on average.
| EXEL | VG | |
|---|---|---|
Market Cap | $14.62B | $33.23B |
Volume | 2,684,957 | 12,625,066 |
Sector | Health | Energy |
52-Week High | $59.13 | $17.53 |
52-Week Low | $34.54 | $5.92 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $13.95B | $72.61B |
Dividend Yield | — | 1.2% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Venture Global develops, builds, and operates liquefied natural gas export facilities. Its projects connect U.S. natural gas supply with global LNG markets.
Read more on VG →